14-day Premium Trial Subscription Try For FreeTry Free
$11.71
+0.600 (+5.40%)
At Close: May 03, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $141.16 $183.01 Friday, 3rd May 2024 ZNTL stock ended at $11.71. This is 5.40% more than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 5.76% from a day low at $11.45 to a day high of $12.11.
90 days $141.16 $227.30
52 weeks $84.73 $227.30

Historical Zentalis Pharmaceuticals Inc. prices

Date Open High Low Close Volume
Dec 08, 2023 $12.21 $13.08 $11.85 $12.96 847 852
Dec 07, 2023 $11.82 $12.42 $11.82 $12.28 589 544
Dec 06, 2023 $11.70 $12.47 $11.40 $11.97 725 613
Dec 05, 2023 $11.42 $11.84 $11.19 $11.65 425 042
Dec 04, 2023 $11.22 $11.72 $11.22 $11.56 478 481
Dec 01, 2023 $11.18 $11.40 $10.51 $11.34 558 717
Nov 30, 2023 $11.00 $11.40 $10.93 $11.25 703 970
Nov 29, 2023 $10.59 $11.14 $10.50 $10.61 458 819
Nov 28, 2023 $10.54 $10.54 $10.05 $10.44 409 163
Nov 27, 2023 $10.72 $10.75 $10.32 $10.43 576 839
Nov 24, 2023 $10.43 $10.87 $10.39 $10.85 225 925
Nov 22, 2023 $10.58 $10.60 $10.26 $10.42 447 519
Nov 21, 2023 $10.80 $10.90 $10.33 $10.35 469 538
Nov 20, 2023 $11.33 $11.50 $10.67 $10.82 425 175
Nov 17, 2023 $11.33 $11.61 $11.25 $11.35 585 639
Nov 16, 2023 $11.54 $11.55 $10.56 $11.22 834 074
Nov 15, 2023 $11.75 $12.48 $11.70 $11.72 677 354
Nov 14, 2023 $10.96 $11.79 $10.86 $11.74 1 670 275
Nov 13, 2023 $9.83 $10.37 $9.58 $10.26 1 604 079
Nov 10, 2023 $9.90 $10.05 $9.60 $9.84 1 862 214
Nov 09, 2023 $10.18 $10.40 $9.88 $9.97 1 465 607
Nov 08, 2023 $10.03 $10.31 $9.56 $10.00 3 744 381
Nov 07, 2023 $12.00 $12.33 $9.74 $10.20 7 521 441
Nov 06, 2023 $17.90 $18.24 $12.10 $12.48 4 605 939
Nov 03, 2023 $16.90 $18.02 $16.73 $17.88 971 574
Click to get the best stock tips daily for free!

About Zentalis Pharmaceuticals Inc.

Zentalis Pharmaceuticals. Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics for the treatment of various cancers. Its lead product candidate includes the ZN-c3, an inhibitor of WEE1, a protein tyrosine kinase, which is in Phase 2 clinical trial for the treatment of advanced solid tumors; Phase 1/2 clinical trial for the treatment of advanced solid tumors as a monotherapy and in an ... ZNTL Profile

Golden Star

Ticker Date Change Price
CVBF May 01 2.75% $16.75
FTSL May 01 0.282% $46.03
EQC Apr 30 0.694% $18.72
HRB Apr 30 0.635% $47.23
BSCQ Apr 30 0.576% $19.09
BSJP Apr 29 0.306% $22.91
LYG Apr 29 1.56% $2.56
ORA Apr 29 4.68% $64.48
DHT Apr 24 3.10% $11.28
LPLA Apr 19 3.12% $262.59
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT